info@seagull-health.com
SeagullHealth
语言:
search
new
Dietary habits of Infiglatinib patients
512
Article source: Seagull Pharmacy
Sep 28, 2026

Infigratinib must be taken on an empty stomach, and food can significantly affect its absorption. Patients should understand the timing of dosing and meals, and avoid certain foods and gastric acid-reducing medications.

I. Timing Requirements for Dosing and Meals

1. Take on an Empty Stomach

Take at least 1 hour before or at least 2 hours after food.

Take once daily, at approximately the same time each day.

2. Swallow Whole

Capsules must be swallowed whole with water and must not be crushed, chewed, or dissolved.

If swallowing capsules is difficult, inform the doctor.

3. Missed Dose and Vomiting

If a dose is missed by less than 4 hours, it may be taken the same day.

If more than 4 hours have passed or vomiting occurs after dosing, the dose should not be made up; resume the regular schedule the next day.

Do not double the dose to make up for a missed dose.

II. Effects of Food on Drug Absorption

1. Avoid Taking with Food

Taking with food significantly increases drug exposure, especially with high-fat, high-calorie meals.

Low-fat, low-calorie meals also increase drug exposure.

Therefore, dosing on an empty stomach must be maintained to reduce fluctuations in exposure.

2. Avoid Grapefruit and Its Products

Grapefruit products should not be eaten or drunk during treatment.

Grapefruit can affect CYP3A4-mediated metabolism and may alter drug concentrations.

3. Maintain a Regular Diet

Dosing times and meal times should be scheduled consistently and not changed arbitrarily.

If decreased appetite occurs during treatment, ensure adequate calorie and protein intake.

III. Coordination of Gastric Acid-Reducing Medications with Diet

1. Avoid Proton Pump Inhibitors

Proton pump inhibitors should be avoided during treatment.

These drugs can reduce the absorption of infigratinib and may affect efficacy.

2. Interval for H2 Receptor Antagonists

If an H2 receptor antagonist cannot be avoided, take it 2 hours before or 10 hours after infigratinib.

Strict interval dosing can reduce interference with drug absorption.

3. Interval for Locally Acting Antacids

If a locally acting antacid is needed, take it 2 hours before or 2 hours after infigratinib.

It must also be staggered from infigratinib.

4. Attention to Dry Mouth and Taste Changes

Dry mouth and taste changes are common; drink appropriate amounts of water and choose light, easy-to-digest foods.

If oral discomfort affects eating, inform the doctor for management.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
WeChat Scan
Free Inquiry
Recommended Articles
Special population use of Infiglatinib
Infigratinib is used to treat cholangiocarcinoma with FGFR2 fusion or rearrangement. Dosing in special populations requires individualized adjustment based on factors such as hepatic and renal functio...
Adverse reactions of Cenobamate
Cenobamate is used for partial-onset seizures in adults. Its adverse reactions involve multiple systems including allergic, cardiac, neurological, and psychiatric systems, requiring focused monitoring...
Dietary precautions for Cenobamate
Cenobamate is taken orally for partial-onset seizures in adults. Its dietary precautions mainly involve administration methods, alcohol, and the synergistic effects of central nervous system depressan...
Special population use of Cenobamate
Cenobamate is used for partial-onset seizures in adults. Dosing in special populations should be adjusted based on hepatic and renal function, age, and physiological status to ensure safety.I. Use in ...
Adverse reactions of Infigratinib
Infigratinib is used to treat cholangiocarcinoma with FGFR2 fusion or rearrangement, and its adverse reactions involve multiple systems. Key monitoring areas include ocular effects, phosphate metaboli...
Special population medication for Vadadustat
Vadadustat is used in adults with anemia of chronic kidney disease who have been on dialysis for at least 3 months, and use in special populations requires careful assessment of risks and benefits.1. ...
Dietary precautions for patients with Vadadustat
Vadadustat is an oral treatment for anemia of chronic kidney disease, and diet and medication timing directly affect efficacy and safety, requiring special attention.1. Basic Relationship Between Medi...
Side effects of Vadadustat
Vadadustat is used for anemia of chronic kidney disease in dialysis patients and may cause multiple types of adverse reactions involving the cardiovascular, hepatic, and gastrointestinal systems, requ...
Related Articles
Adverse reactions of Infigratinib
Infigratinib is used to treat cholangiocarcinoma with FGFR2 fusion or rearrangement, and its adverse reactions involve multiple systems. Key monitoring areas include ocular effects, phosphate metaboli...
Dietary habits of Infiglatinib patients
Infigratinib must be taken on an empty stomach, and food can significantly affect its absorption. Patients should understand the timing of dosing and meals, and avoid certain foods and gastric acid-re...
Special population use of Infiglatinib
Infigratinib is used to treat cholangiocarcinoma with FGFR2 fusion or rearrangement. Dosing in special populations requires individualized adjustment based on factors such as hepatic and renal functio...
Indications of Infigratinib
Infigratinib is an oral kinase inhibitor targeting FGFR2, indicated for patients with specific gene mutations in cholangiocarcinoma.I. Indications1. Infigratinib is indicated for adult patients with p...
Common Side Effects of Infigratinib
Infigratinib has shown clear efficacy in the treatment of FGFR2-mutant cholangiocarcinoma, but may also cause various side effects.I. Common Side Effects1. Ocular Side Effects:(1) The most common ocul...
New Drugs
Cenobamate(Xcopri)
Cenobamate(Xcopri)
It is used for the treatment of partial-onset seizures in adults (with or...
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved